Workup for Increasing Frequency of Headaches with Known Pituitary Tumor
For a patient with a known pituitary tumor experiencing increasing frequency of headaches, a high-resolution pituitary MRI with pre-contrast (T1 and T2) and post-contrast-enhanced (T1) thin-sliced sequences is the recommended first-line diagnostic evaluation. 1
Initial Imaging Evaluation
MRI of the sella with pituitary protocol:
- Pre-contrast T1 and T2 weighted sequences
- Post-contrast T1 weighted sequences
- Thin-sliced imaging (2mm slices)
- Include post-contrast volumetric gradient (recalled) echo sequences for increased sensitivity 1
- Should be interpreted by a neuroradiologist
Benefits of specialized MRI:
Consider 3-Tesla MRI:
- Provides enhanced anatomical definition
- May improve surgical planning if intervention becomes necessary 1
Clinical Evaluation to Accompany Imaging
Complete visual assessment:
Hormonal evaluation:
Differential Diagnosis for Worsening Headaches
- Tumor growth - requires comparison with previous imaging 2
- Pituitary apoplexy - acute hemorrhage or infarction within the tumor 1
- Cystic degeneration - can cause sudden expansion 4
- Unrelated headache disorder - migraine, tension headache, etc.
Management Algorithm Based on Findings
If imaging shows tumor growth with mass effect:
- Urgent surgical consultation if visual pathway compression is present
- Consider transsphenoidal surgery, especially with documented tumor growth, visual pathway compression, or symptomatic hypopituitarism 2
If imaging shows pituitary apoplexy:
If imaging shows stable tumor:
- Consider alternative causes for headaches
- Neurological consultation for headache management
- Continue regular surveillance of the pituitary tumor
Follow-up Recommendations
For stable tumors after evaluation:
- Follow-up MRI at 6 months, then at 1,2,3, and 5 years 2
- Regular monitoring for development or worsening of hypopituitarism
- Periodic visual field testing if tumor is near the optic chiasm
For macroadenomas (≥10mm):
- More vigilant monitoring as they grow more frequently than microadenomas 2
- Annual MRI for 3 years with gradual reduction in frequency thereafter
Important Caveats
- Gadolinium contrast should be used judiciously, especially in patients with renal impairment
- Consider unenhanced T1 and T2 sequences for follow-up imaging to minimize gadolinium exposure 1
- Headaches may be attributable to the tumor itself or could be unrelated, requiring careful clinical correlation
- Venous sampling is not indicated for evaluation of headaches with known pituitary tumors unless there is suspicion of hormone hypersecretion with equivocal imaging 1